Detalhe da pesquisa
1.
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.
Clin Cancer Res
; 29(12): 2324-2335, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939530
2.
SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples.
Clin Epigenetics
; 14(1): 37, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35272673
3.
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer.
Commun Biol
; 5(1): 897, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050516
4.
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
J Clin Invest
; 132(21)2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317634
5.
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer.
Endocr Relat Cancer
; 28(9): 645-655, 2021 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280123
6.
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
Mol Oncol
; 15(9): 2330-2344, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604999
7.
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.
J Clin Oncol
; 39(26): 2926-2937, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197212
8.
Pairing Microwell Arrays with an Affordable, Semiautomated Single-Cell Aspirator for the Interrogation of Circulating Tumor Cell Heterogeneity.
SLAS Technol
; 25(2): 162-176, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31983266